STOCK TITAN
  1. Home
  2. News
  3. HARP

Harpoon Therapeutics (HARP) Stock News, Aug-Oct 2023

HARP NASDAQ
News

Harpoon Therapeutics to Host Webcast Reviewing HPN328 Interim Data Presented at ESMO Congress 2023 on October 23, 2023

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
27.99%
Tags
conferences
-
News

Harpoon Therapeutics to Present Interim Tolerability and Response Data from Phase 1/2 Clinical Trial of T Cell Engager HPN328 at ESMO Congress 2023

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.3%
Tags
conferences clinical trial
-
News

Harpoon Therapeutics Presents HPN217 Interim Phase 1 Data at the IMS Annual Meeting

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.96%
Tags
clinical trial
News

Harpoon Therapeutics Announces First Patients with Small Cell Lung Cancer Dosed in HPN328 Combination Cohort

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.48%
Tags
none
-
News

Harpoon Therapeutics Provides an Update on the HPN217 Development and Option Agreement with AbbVie

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-17.43%
Tags
none
-
News

Harpoon Therapeutics Abstract for HPN217 Accepted for Poster Presentation at the 20th International Myeloma Society Annual Meeting

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.59%
Tags
none
News

Harpoon Therapeutics to Host KOL Event in Person and via Webcast on September 15, 2023

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.9%
Tags
conferences
-
News

Harpoon Therapeutics to Participate in Two Upcoming Investor Conferences in September

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.9%
Tags
conferences
-
News

Harpoon Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.89%
Tags
earnings
News

Harpoon Therapeutics to Participate in Two Upcoming Investor Conferences in August

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.25%
Tags
conferences